+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell-based Assay Market Research Report by Offerings (Consumables, Instruments, and Services), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4858028
  • Report
  • April 2022
  • Region: Global
  • 213 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Cell Biolabs, Inc.
  • Cisbio
  • Danaher Corporation
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
The Global Cell-based Assay Market size was estimated at USD 14.46 billion in 2021, USD 15.50 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.34% to reach USD 22.13 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cell-based Assay to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Offerings, the market was studied across Consumables, Instruments, and Services. The Consumables is further studied across Assay Kits, Cell Lines, Microplates, Probes & Labels, and Reagents.
  • Based on Application, the market was studied across Basic Research and Drug Discovery. The Drug Discovery is further studied across Pharmacodynamic Studies, Pharmacokinetic Studies, and Toxicity Studies.
  • Based on End User, the market was studied across Academic & Government Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cell-based Assay market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell-based Assay Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell-based Assay Market, including Becton, Dickinson and Company, Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Cisbio, Danaher Corporation, GE Healthcare, Lonza Group Ltd., Merck KGaA, Perkinelmer, Inc., Promega Corporation, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cell-based Assay Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell-based Assay Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell-based Assay Market?
4. What is the competitive strategic window for opportunities in the Global Cell-based Assay Market?
5. What are the technology trends and regulatory frameworks in the Global Cell-based Assay Market?
6. What is the market share of the leading vendors in the Global Cell-based Assay Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell-based Assay Market?
Frequently Asked Questions about the Global Cell-based Assay Market

What is the estimated value of the Global Cell-based Assay Market?

The Global Cell-based Assay Market was estimated to be valued at $14.5 Billion in 2021.

What is the growth rate of the Global Cell-based Assay Market?

The growth rate of the Global Cell-based Assay Market is 7.3%, with an estimated value of $22.1 Billion by 2027.

What is the forecasted size of the Global Cell-based Assay Market?

The Global Cell-based Assay Market is estimated to be worth $22.1 Billion by 2027.

Who are the key companies in the Global Cell-based Assay Market?

Key companies in the Global Cell-based Assay Market include Becton, Dickinson and Company, Cell Biolabs, Inc., Cell Signaling Technology, Inc., Charles River Laboratories, Inc., Cisbio, Danaher Corporation, GE Healthcare, Lonza Group Ltd. and Perkinelmer, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cell Biolabs, Inc.
  • Cisbio
  • Danaher Corporation
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KGaA

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cardiovascular & infectious disease, diabetes, and cancer worldwide
5.1.1.2. Awareness regarding advantages of cell-based assays over traditional treatments
5.1.1.3. Rising worldwide demand for novel drugs and treatments
5.1.2. Restraints
5.1.2.1. Limited skilled professionals
5.1.3. Opportunities
5.1.3.1. Potential in emerging economies
5.1.3.2. Rising use of cell-based assays in various ultra-high throughput screening
5.1.3.3. Growing number of in-vitro drug studies based on cell-based assays
5.1.4. Challenges
5.1.4.1. Unfavourable regulatory framework
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cell-based Assay Market, by Offerings
6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits
6.2.2. Cell Lines
6.2.3. Microplates
6.2.4. Probes & Labels
6.2.5. Reagents
6.3. Instruments
6.4. Services
7. Cell-based Assay Market, by Application
7.1. Introduction
7.2. Basic Research
7.3. Drug Discovery
7.3.1. Pharmacodynamic Studies
7.3.2. Pharmacokinetic Studies
7.3.3. Toxicity Studies
8. Cell-based Assay Market, by End User
8.1. Introduction
8.2. Academic & Government Institutes
8.3. Contract Research Organizations
8.4. Pharmaceutical & Biotechnology Companies
9. Americas Cell-based Assay Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cell-based Assay Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Cell-based Assay Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Becton, Dickinson and Company
13.2. Cell Biolabs, Inc.
13.3. Cell Signaling Technology, Inc.
13.4. Charles River Laboratories, Inc.
13.5. Cisbio
13.6. Danaher Corporation
13.7. GE Healthcare
13.8. Lonza Group Ltd.
13.9. Merck KGaA
13.10. Perkinelmer, Inc.
13.11. Promega Corporation
13.12. Thermo Fisher Scientific Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CELL-BASED ASSAY MARKET: DYNAMICS
FIGURE 2. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2027
FIGURE 5. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, 2019-2027 (USD BILLION)
FIGURE 10. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 11. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, 2019-2027 (USD BILLION)
FIGURE 16. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 17. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD BILLION)
FIGURE 18. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 19. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, 2019-2027 (USD BILLION)
FIGURE 20. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 21. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 22. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2027
FIGURE 24. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, 2019-2027 (USD BILLION)
FIGURE 31. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 32. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, 2019-2027 (USD BILLION)
FIGURE 33. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 34. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 35. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2027
FIGURE 37. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, 2019-2027 (USD BILLION)
FIGURE 38. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2027 (USD BILLION)
FIGURE 40. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD BILLION)
FIGURE 42. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 43. AMERICAS CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. ARGENTINA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. BRAZIL CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. CANADA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. MEXICO CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. UNITED STATES CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. CHINA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. INDIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. INDONESIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. JAPAN CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. MALAYSIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. SINGAPORE CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. TAIWAN CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. THAILAND CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 62. FRANCE CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 63. GERMANY CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 64. ITALY CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. QATAR CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. RUSSIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. SPAIN CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. GLOBAL CELL-BASED ASSAY MARKET: FPNV POSITIONING MATRIX
FIGURE 74. GLOBAL CELL-BASED ASSAY MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL-BASED ASSAY MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CELL-BASED ASSAY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY OFFERINGS, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY ASSAY KITS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 15. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CELL LINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY REGION, 2019-2027 (USD BILLION)
TABLE 20. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY MICROPLATES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY REGION, 2019-2027 (USD BILLION)
TABLE 25. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY STATE, 2019-2027 (USD BILLION)
TABLE 27. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY PROBES & LABELS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 30. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 32. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY REAGENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 35. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 37. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY REGION, 2019-2027 (USD BILLION)
TABLE 40. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 42. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY SERVICES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 45. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2019-2027 (USD BILLION)
TABLE 46. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY STATE, 2019-2027 (USD BILLION)
TABLE 48. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2019-2027 (USD BILLION)
TABLE 53. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 56. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 58. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY PHARMACODYNAMIC STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 61. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 63. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 66. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 68. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY TOXICITY STUDIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 71. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2019-2027 (USD BILLION)
TABLE 72. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 73. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY STATE, 2019-2027 (USD BILLION)
TABLE 74. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 77. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 78. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 79. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. GLOBAL CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 82. AMERICAS CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 83. UNITED STATES CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 84. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. AMERICAS CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 87. ARGENTINA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. BRAZIL CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 89. CANADA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 90. MEXICO CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 91. UNITED STATES CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. ASIA-PACIFIC CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 93. AUSTRALIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 94. CHINA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 95. INDIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. INDONESIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 97. JAPAN CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 98. MALAYSIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 99. PHILIPPINES CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. SINGAPORE CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 101. SOUTH KOREA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 102. TAIWAN CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 103. THAILAND CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 105. FRANCE CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 106. GERMANY CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 107. ITALY CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 108. NETHERLANDS CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 109. QATAR CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 110. RUSSIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 111. SAUDI ARABIA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 112. SOUTH AFRICA CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 113. SPAIN CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 114. UNITED ARAB EMIRATES CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 115. UNITED KINGDOM CELL-BASED ASSAY MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. GLOBAL CELL-BASED ASSAY MARKET: SCORES
TABLE 117. GLOBAL CELL-BASED ASSAY MARKET: BUSINESS STRATEGY
TABLE 118. GLOBAL CELL-BASED ASSAY MARKET: PRODUCT SATISFACTION
TABLE 119. GLOBAL CELL-BASED ASSAY MARKET: RANKING
TABLE 120. GLOBAL CELL-BASED ASSAY MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 121. GLOBAL CELL-BASED ASSAY MARKET: MERGER & ACQUISITION
TABLE 122. GLOBAL CELL-BASED ASSAY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 123. GLOBAL CELL-BASED ASSAY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 124. GLOBAL CELL-BASED ASSAY MARKET: INVESTMENT & FUNDING
TABLE 125. GLOBAL CELL-BASED ASSAY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 126. GLOBAL CELL-BASED ASSAY MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Becton, Dickinson and Company
  • Cell Biolabs, Inc.
  • Cell Signaling Technology, Inc.
  • Charles River Laboratories, Inc.
  • Cisbio
  • Danaher Corporation
  • GE Healthcare
  • Lonza Group Ltd.
  • Merck KGaA
  • Perkinelmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...